These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 20674)

  • 21. Hypotensive action of beta-blocking drugs injected into the cerebral ventricle of the rat.
    Wepierre J; Lindenbaum A; Porquet D; Cohen Y
    Arch Int Pharmacodyn Ther; 1978 Mar; 232(1):158-65. PubMed ID: 27151
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antiarrhythmic effects of four different beta-adrenergic blockers in the mouse chloroform arrhythmia model.
    Reynolds RD; Calzadilla SV
    Res Commun Chem Pathol Pharmacol; 1980 Aug; 29(2):361-4. PubMed ID: 6106265
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Heart rate after combined vagal and sympathetic blockade with atropine and different beta-receptor blocking agents.
    Fenyvesi T; Káldor A; Sebestyén K
    Int J Clin Pharmacol; 1973 Nov; 8(3):254-7. PubMed ID: 4149237
    [No Abstract]   [Full Text] [Related]  

  • 24. Effects of beta adrenergic blocking drugs and trifluperidol on intestinal motility and splanchnic nerve activity in cats.
    Szenohradszky J; Gibiszer PK; Pórszász J; Gács E
    Acta Chir Hung; 1983; 24(4):307-21. PubMed ID: 6670434
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Frequency-dependent block of nerve conduction by beta-adrenergic blocking agents.
    Sada H; Ban T
    Arch Int Pharmacodyn Ther; 1981 Nov; 254(1):134-44. PubMed ID: 6121535
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Local anesthetic activity of beta-adrenergic blocking drugs in the Crayfish giant axon, with reference to calcium ion.
    Ishida H; Sasa M; Takaori S
    Jpn J Pharmacol; 1980 Oct; 30(5):607-19. PubMed ID: 6110795
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical pharmacokinetics of beta-adrenoceptor blocking drugs in thyroid disease.
    Feely J
    Clin Pharmacokinet; 1983; 8(1):1-16. PubMed ID: 6132696
    [No Abstract]   [Full Text] [Related]  

  • 28. Structure-basicity and structure-affinity relationships of beta-adrenergic blocking agents.
    Fernández B; Kaumann AJ
    Acta Physiol Lat Am; 1975; 25(1):45-51. PubMed ID: 3943
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of beta adrenergic blocking agents on erythropoietin production in rabbits exposed to hypoxia.
    Fink GD; Paulo LG; Fisher JW
    J Pharmacol Exp Ther; 1975 Apr; 193(1):176-81. PubMed ID: 237111
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Beta-adrenergic blockers. Choosing among them.
    Vlietstra RE; McGoon MD
    Postgrad Med; 1984 Sep; 76(3):71-3, 76-7, 80. PubMed ID: 6147832
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Dosage of digitalis glycosides and beta blockers in renal insufficiency].
    Ohnhaus EE
    Med Klin; 1976 Oct; 71(44):1867-72. PubMed ID: 11399
    [No Abstract]   [Full Text] [Related]  

  • 32. Studies on relationships between chemical structure and beta-blocking potency of bopindolol and its two metabolites.
    Nagatomo T; Ishiguro M; Ohnuki T; Hattori K; Hosohata Y; Takatsu N; Katayama H; Watanabe K
    Life Sci; 1998; 62(17-18):1597-600. PubMed ID: 9585142
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tryptophan residues of the gamma subunit of 7S nerve growth factor: intrinsic fluorescence, solute quenching, and N-bromosuccinimide oxidation.
    Rao AG; Neet KE
    Biochemistry; 1982 Dec; 21(26):6843-50. PubMed ID: 7159567
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Protection by beta-blocking agents against free radical-mediated sarcolemmal lipid peroxidation.
    Mak IT; Weglicki WB
    Circ Res; 1988 Jul; 63(1):262-6. PubMed ID: 2898307
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Studies of the effect of thyroid dysfunction on the elimination of beta-adrenoreceptor blocking drugs.
    Bell JM; Russell CJ; Nelson JK; Kelly JG; McDevitt DG
    Br J Clin Pharmacol; 1977 Feb; 4(1):79-82. PubMed ID: 14661
    [No Abstract]   [Full Text] [Related]  

  • 36. Propranolol and sotalol metabolism after a drinking party.
    Sotaniemi EA; Anttila M; Rautio A; Stengård J; Saukko P; Järvensivu P
    Clin Pharmacol Ther; 1981 Jun; 29(6):705-10. PubMed ID: 7226702
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synthesis of 4'-hydroxypropranolol sulfate, a major non-beta-blocking propranolol metabolite in man.
    Oatis JE; Walle T; Daniell HB; Gaffney TE; Knapp DR
    J Med Chem; 1985 Jun; 28(6):822-4. PubMed ID: 2861287
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High plasma protein binding as a parameter in the selection of betablockers for lactating women.
    Riant P; Urien S; Albengres E; Duche JC; Tillement JP
    Biochem Pharmacol; 1986 Dec; 35(24):4579-81. PubMed ID: 2878668
    [No Abstract]   [Full Text] [Related]  

  • 39. An experimental design based quantitative structure-activity relationship study on beta-adrenergic blocking agents using PLS.
    Norinder U
    Drug Des Discov; 1991 Dec; 8(2):127-36. PubMed ID: 1686560
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sotalol: another beta adrenergic blocking agent?
    Ahlquist RP
    J Clin Pharmacol; 1979; 19(8-9 Pt 2):495-6. PubMed ID: 489768
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.